Advanced search
Publication Cover
Expert Opinion on Medical Diagnostics Volume 1, 2007 - Issue 2
Journal homepage
33
Views
2
CrossRef citations to date
0
Altmetric
Review

The mitochondrial genome: a biosensor for early cancer detection?

Ryan L Parr Vice President of Research, Genesis Genomics, Inc., 290 Munro Street, Ste 1000, Thunder Bay, Ontario, P7A 7T1, Canada +1 807 346 8100; +1 807 346 8105; [email protected]
,
John P Jakupciak Principal Investigator, National Institute of Standards and Technology, Biochemical Science Division, Gaithersburg, MD 20899, USA [email protected]
, PhD,
Mark A Birch-Machin Professor, Newcastle University, Dermatological Sciences, Institute of Cellular Medicine, Newcastle upon Tyne, NE2 4HH, UK [email protected]
, PhD &
Gabriel D Dakubo Senior Scientist, Genesis Genomics, Inc., 290 Munro Street, Ste 1000, Thunder Bay, Ontario, P7A 7T1, Canada [email protected]
, BSc MB ChB
Pages 169-182 | Published online: 23 Oct 2007

Bibliography

  • POLYAK K, LI Y, ZHU H et al.: Somatic mutations of the mitochondrial genome in human colorectal tumours. Nat. Genet. (1998) 20(3):291-293.
  • WARBURG O: On the origin of cancer cells. Science (1956) 123(3191):309-314.
  • LU F: Reactive oxygen species in cancer, too much or too little? Med. Hypotheses (2007) (In Press).
  • PETROS JA, BAUMANN AK, RUIZ-PESINI E et al.: mtDNA mutations increase tumorigenicity in prostate cancer. Proc. Natl. Acad. Sci. USA (2005) 102(3):719-724.
  • DAKUBO GD, JAKUPCIAK JP, BIRCH-MACHIN MA, PARR RL: Clinical implications and utility of field cancerization. Cancer Cell Int. (2007) 7:2.
  • JONES JB, SONG JJ, HEMPEN PM, PARMIGIANI G, HRUBAN RH, KERN SE: Detection of mitochondrial DNA mutations in pancreatic cancer offers a “mass”-ive advantage over detection of nuclear DNA mutations. Cancer Res. (2001) 61(4):1299-1304.
  • PARR RL, MAKI J, REGULY B et al.: The pseudo-mitochondrial genome influences mistakes in heteroplasmy interpretation. BMC Genomics (2006) 7:185.
  • PARFAIT B, RUSTIN P, MUNNICH A, ROTIG A: Co-amplification of nuclear pseudogenes and assessment of heteroplasmy of mitochondrial DNA mutations. Biochem. Biophys. Res. Commun. (1998) 247(1):57-59.
  • JAKUPCIAK JP, WANG W, MARKOWITZ ME et al.: Mitochondrial DNA as a cancer biomarker. J. Mol. Diagn. (2005) 7(2):258-267.
  • ANDERSON S, BANKIER AT, BARRELL BG et al.: Sequence and organization of the human mitochondrial genome. Nature (1981) 290(5806):457-465.
  • SALAS A, YAO YG, MACAULAY V, VEGA A, CARRACEDO A, BANDELT HJ: A critical reassessment of the role of mitochondria in tumorigenesis. PLoS Med. (2005) 2(11):E296.
  • ZANSSEN S, SCHON EA: Mitochondrial DNA mutations in cancer. PLoS Med. (2005) 2(11):E401.
  • GUO XG, GUO QN: Mutations in the mitochondrial DNA D-Loop region occur frequently in human osteosarcoma. Cancer Lett. (2006) 239(1):151-155.
  • LIANG BC: Evidence for association of mitochondrial DNA sequence amplification and nuclear localization in human low-grade gliomas. Mutat. Res. (1996) 354(1):27-33.
  • KIRCHES E, KRAUSE G, WARICH-KIRCHES M et al.: High frequency of mitochondrial DNA mutations in glioblastoma multiforme identified by direct sequence comparison to blood samples. Int. J. Cancer (2001) 93(4):534-538.
  • MONTANINI L, REGNA-GLADIN C, EOLI M et al.: Instability of mitochondrial DNA and MRI and clinical correlations in malignant gliomas. J. Neurooncol. (2005) 74(1):87-89.
  • WONG LJ, LUETH M, LI XN, LAU CC, VOGEL H: Detection of mitochondrial DNA mutations in the tumor and cerebrospinal fluid of medulloblastoma patients. Cancer Res. (2003) 63(14):3866-3871.
  • TAN DJ, BAI RK, WONG LJ: Comprehensive scanning of somatic mitochondrial DNA mutations in breast cancer. Cancer Res. (2002) 62(4):972-976.
  • PARRELLA P, XIAO Y, FLISS M et al.: Detection of mitochondrial DNA mutations in primary breast cancer and fine-needle aspirates. Cancer Res. (2001) 61(20):7623-7626.
  • ROSSON D, KESHGEGIAN AA: Frequent mutations in the mitochondrial control region DNA in breast tissue. Cancer Lett. (2004) 215(1):89-94.
  • BRANDON MC, LOTT MT, NGUYEN KC et al.: MITOMAP: a human mitochondrial genome database – 2004 update. Nucleic Acids Res. (2005) 33(Database Issue):D611-D613.
  • TSENG LM, YIN PH, CHI CW et al.: Mitochondrial DNA mutations and mitochondrial DNA depletion in breast cancer. Genes Chromosomes Cancer (2006) 45(7):629-638.
  • PARR RL, DAKUBO GD, CRANDALL KA et al.: Somatic mitochondrial DNA mutations in prostate cancer and normal appearing adjacent glands in comparison to age-matched prostate samples without malignant histology. J. Mol. Diagn. (2006) 8(3):312-319.
  • DANI MA, DANI SU, LIMA SP et al.: Less DeltamtDNA4977 than normal in various types of tumors suggests that cancer cells are essentially free of this mutation. Genet. Mol. Res. (2004) 3(3):395-409.
  • MAMBO E, CHATTERJEE A, XING M et al.: Tumor-specific changes in mtDNA content in human cancer. Int. J. Cancer (2005) 116(6):920-924.
  • WANG Y, LIU VW, TSANG PC et al.: Microsatellite instability in mitochondrial genome of common female cancers. Int. J. Gynecol. Cancer (2006) 16(Suppl. 1):259-266.
  • RICHARD SM, BAILLIET G, PAEZ GL, BIANCHI MS, PELTOMAKI P, BIANCHI NO: Nuclear and mitochondrial genome instability in human breast cancer. Cancer Res. (2000) 60(15):4231-4237.
  • ZHU W, QIN W, BRADLEY P, WESSEL A, PUCKETT CL, SAUTER ER: Mitochondrial DNA mutations in breast cancer tissue and in matched nipple aspirate fluid. Carcinogenesis (2005) 26(1):145-152.
  • SHARMA H, SINGH A, SHARMA C, JAIN SK, SINGH N: Mutations in the mitochondrial DNA D-loop region are frequent in cervical cancer. Cancer Cell Int. (2005) 5:34.
  • ALLALUNIS-TURNER J, MA I, HANSON J, PEARCEY RG: mtDNA mutations in invasive cervix tumors: a retrospective analysis. Cancer Lett. (2006) 243(2):193-201.
  • ALONSO A, MARTIN P, ALBARRAN C et al.: Detection of somatic mutations in the mitochondrial DNA control region of colorectal and gastric tumors by heteroduplex and single-strand conformation analysis. Electrophoresis (1997) 18(5):682-685.
  • HABANO W, SUGAI T, YOSHIDA T, NAKAMURA S: Mitochondrial gene mutation, but not large-scale deletion, is a feature of colorectal carcinomas with mitochondrial microsatellite instability. Int. J. Cancer (1999) 83(5):625-629.
  • HABANO W, NAKAMURA S, SUGAI T: Microsatellite instability in the mitochondrial DNA of colorectal carcinomas: evidence for mismatch repair systems in mitochondrial genome. Oncogene (1998) 17(15):1931-1937.
  • AIKHIONBARE FO, KHAN M, CAREY D, OKOLI J, GO R: Is cumulative frequency of mitochondrial DNA variants a biomarker for colorectal tumor progression? Mol. Cancer (2004) 3:30.
  • LIEVRE A, CHAPUSOT C, BOUVIER AM et al.: Clinical value of mitochondrial mutations in colorectal cancer. J. Clin. Oncol. (2005) 23(15):3517-3525.
  • GULENG G, LOVIG T, MELING GI, ANDERSEN SN, ROGNUM TO: Mitochondrial microsatellite instability in colorectal carcinomas-frequency and association with nuclear microsatellite instability. Cancer Lett. (2005) 219(1):97-103.
  • KOSE K, HIYAMA T, TANAKA S, YOSHIHARA M, YASUI W, CHAYAMA K: Somatic mutations of mitochondrial DNA in digestive tract cancers. J. Gastroenterol. Hepatol. (2005) 20(11):1679-1684.
  • KIM HS, LIM HS, LEE SH et al.: Mitochondrial microsatellite instability of colorectal cancer stroma. Int. J. Cancer (2006) 119(11):2607-2611.
  • LIU VW, YANG HJ, WANG Y et al.: High frequency of mitochondrial genome instability in human endometrial carcinomas. Br. J. Cancer (2003) 89(4):697-701.
  • WANG Y, XUE WC, LIU VW, NGAN HY: Detection of mosaic pattern of mitochondrial DNA alterations in different populations of cells from the same endometrial tumor. Mitochondrion (2007) 7(1-2):171-175.
  • SEMCZUK A, LORENC A, PUTOWSKI L et al.: Clinicoprognostical features of endometrial cancer patients with somatic mtDNA mutations. Oncol. Rep. (2006) 16(5):1041-1045.
  • PEJOVIC T, LADNER D, INTENGAN M et al.: Somatic D-loop mitochondrial DNA mutations are frequent in uterine serous carcinoma. Eur. J. Cancer (2004) 40(16):2519-2524.
  • HIBI K, NAKAYAMA H, YAMAZAKI T et al.: Mitochondrial DNA alteration in esophageal cancer. Int. J. Cancer (2001) 92(3):319-321.
  • KUMIMOTO H, YAMANE Y, NISHIMOTO Y et al.: Frequent somatic mutations of mitochondrial DNA in esophageal squamous cell carcinoma. Int. J. Cancer (2004) 108(2):228-231.
  • ABNET CC, HUPPI K, CARRERA A et al.: Control region mutations and the ‘common deletion are frequent in the mitochondrial DNA of patients with esophageal squamous cell carcinoma. BMC Cancer (2004) 4:30.
  • MIYAZONO F, SCHNEIDER PM, METZGER R et al.: Mutations in the mitochondrial DNA D-Loop region occur frequently in adenocarcinoma in Barrett's esophagus. Oncogene (2002) 21(23):3780-3783.
  • HABANO W, SUGAI T, NAKAMURA SI, UESUGI N, YOSHIDA T, SASOU S: Microsatellite instability and mutation of mitochondrial and nuclear DNA in gastric carcinoma. Gastroenterology (2000) 118(5):835-841.
  • MAXIMO V, SOARES P, SERUCA R, ROCHA AS, CASTRO P, SOBRINHO-SIMOES M: Microsatellite instability, mitochondrial DNA large deletions, and mitochondrial DNA mutations in gastric carcinoma. Genes Chromosomes Cancer (2001) 32(2):136-143.
  • MAXIMO V, SOARES P, SERUCA R, SOBRINHO-SIMOES M: Comments on: mutations in mitochondrial control region DNA in gastric tumours of Japanese patients. Eur. J. Cancer (1999) 35(9):1407-1408.
  • ZHAO YB, YANG HY, ZHANG XW, CHEN GY: Mutation in D-loop region of mitochondrial DNA in gastric cancer and its significance. World J. Gastroenterol. (2005) 11(21):3304-3306.
  • WU CW, YIN PH, HUNG WY et al.: Mitochondrial DNA mutations and mitochondrial DNA depletion in gastric cancer. Genes Chromosomes Cancer (2005) 44(1):19-28.
  • KAMALIDEHGHAN B, HOUSHMAND M, ISMAIL P, PANAHI MS, AKBARI MH: Delta mtDNA4977 is more common in non-tumoral cells from gastric cancer sample. Arch. Med. Res. (2006) 37(6):730-735.
  • KAMALIDEHGHAN B, HOUSHMAND M, PANAHI MS, ABBASZADEGAN MR, ISMAIL P, SHIROUDI MB: Tumoral cell mtDNA approximately 8.9 kb deletion is more common than other deletions in gastric cancer. Arch. Med. Res. (2006) 37(7):848-853.
  • HA PK, TONG BC, WESTRA WH et al.: Mitochondrial C-tract alteration in premalignant lesions of the head and neck: a marker for progression and clonal proliferation. Clin. Cancer Res. (2002) 8(7):2260-2265.
  • LIEVRE A, BLONS H, HOULLIER AM et al.: Clinicopathological significance of mitochondrial D-Loop mutations in head and neck carcinoma. Br. J. Cancer (2006) 94(5):692-697.
  • PRIOR SL, GRIFFITHS AP, BAXTER JM et al.: Mitochondrial DNA mutations in oral squamous cell carcinoma. Carcinogenesis (2006) 27(5):945-950.
  • POETSCH M, PETERSMANN A, LIGNITZ E, KLEIST B: Relationship between mitochondrial DNA instability, mitochondrial DNA large deletions, and nuclear microsatellite instability in head and neck squamous cell carcinomas. Diagn. Mol. Pathol. (2004) 13(1):26-32.
  • SHAO JY, LI YH, GAO HY et al.: High frequency of common deletion (4981 bp) in mitochondrial DNA in nasopharyngeal carcinoma and its correlation with patient age and clinical stages. Cancer Biol. Ther. (2004) 3(12):1270-1274.
  • HAN YC, KONG WJ, ZHANG S, WANG YJ, WANG Y, CHEN X: Mutation of mitochondrial DNA 4977 bp deletion in laryngeal squamous cell cancer. Ai Zheng (2004) 23(11):1297-1301.
  • SHIEH DB, CHOU WP, WEI YH, WONG TY, JIN YT: Mitochondrial DNA 4,977-bp deletion in paired oral cancer and precancerous lesions revealed by laser microdissection and real-time quantitative PCR. Ann. NY Acad. Sci. (2004) 1011:154-167.
  • ZHOU S, KACHHAP S, SUN W et al.: Frequency and phenotypic implications of mitochondrial DNA mutations in human squamous cell cancers of the head and neck. Proc. Natl. Acad. Sci. USA (2007) 104(18):7540-7545.
  • JIANG WW, MASAYESVA B, ZAHURAK M et al.: Increased mitochondrial DNA content in saliva associated with head and neck cancer. Clin. Cancer Res. (2005) 11(7):2486-2491.
  • KIM MM, CLINGER JD, MASAYESVA BG et al.: Mitochondrial DNA quantity increases with histopathologic grade in premalignant and malignant head and neck lesions. Clin. Cancer Res. (2004) 10(24):8512-8515.
  • SHAO JY, GAO HY, LI YH, ZHANG Y, LU YY, ZENG YX: Quantitative detection of common deletion of mitochondrial DNA in hepatocellular carcinoma and hepatocellular nodular hyperplasia. World J. Gastroenterol. (2004) 10(11):1560-1564.
  • NISHIKAWA M, NISHIGUCHI S, SHIOMI S et al.: Somatic mutation of mitochondrial DNA in cancerous and noncancerous liver tissue in individuals with hepatocellular carcinoma. Cancer Res. (2001) 61(5):1843-1845.
  • NOMOTO S, YAMASHITA K, KOSHIKAWA K, NAKAO A, SIDRANSKY D: Mitochondrial D-loop mutations as clonal markers in multicentric hepatocellular carcinoma and plasma. Clin. Cancer Res. (2002) 8(2):481-487.
  • LEE HC, LI SH, LIN JC, WU CC, YEH DC, WEI YH: Somatic mutations in the D-loop and decrease in the copy number of mitochondrial DNA in human hepatocellular carcinoma. Mutat. Res. (2004) 547(1-2):71-78.
  • TAMORI A, NISHIGUCHI S, NISHIKAWA M et al.: Correlation between clinical characteristics and mitochondrial D-loop DNA mutations in hepatocellular carcinoma. J. Gastroenterol. (2004) 39(11):1063-1068.
  • YIN PH, LEE HC, CHAU GY et al.: Alteration of the copy number and deletion of mitochondrial DNA in human hepatocellular carcinoma. Br. J. Cancer (2004) 90(12):2390-2396.
  • YAMADA S, NOMOTO S, FUJII T et al.: Correlation between copy number of mitochondrial DNA and clinico-pathologic parameters of hepatocellular carcinoma. Eur. J. Surg. Oncol. (2006) 32(3):303-307.
  • SUZUKI M, TOYOOKA S, MIYAJIMA K et al.: Alterations in the mitochondrial displacement loop in lung cancers. Clin. Cancer Res. (2003) 9(15):5636-5641.
  • MATSUYAMA W, NAKAGAWA M, WAKIMOTO J, HIROTSU Y, KAWABATA M, OSAME M: Mitochondrial DNA mutation correlates with stage progression and prognosis in non-small cell lung cancer. Hum. Mutat. (2003) 21(4):441-443.
  • MORANDI L, ASIOLI S, CAVAZZA A, PESSION A, DAMIANI S: Genetic relationship among atypical adenomatous hyperplasia, bronchioloalveolar carcinoma and adenocarcinoma of the lung. Lung Cancer (2007) 56(1):35-42.
  • DAI JG, XIAO YB, MIN JX, ZHANG GQ, YAO K, ZHOU RJ: Mitochondrial DNA 4977 BP deletion mutations in lung carcinoma. Indian J. Cancer (2006) 43(1):20-25.
  • LIU VW, SHI HH, CHEUNG AN et al.: High incidence of somatic mitochondrial DNA mutations in human ovarian carcinomas. Cancer Res. (2001) 61(16):5998-6001.
  • AIKHIONBARE FO, MEHRABI S, KUMARESAN K et al.: Mitochondrial DNA sequence variants in epithelial ovarian tumor subtypes and stages. J. Carcinog. (2007) 6:1.
  • VAN TRAPPEN PO, CULLUP T, TROKE R et al.: Somatic mitochondrial DNA mutations in primary and metastatic ovarian cancer. Gynecol. Oncol. (2007) 104(1):129-133.
  • NAVAGLIA F, BASSO D, FOGAR P et al.: Mitochondrial DNA D-loop in pancreatic cancer: somatic mutations are epiphenomena while the germline 16519 T variant worsens metabolism and outcome. Am. J. Clin. Pathol. (2006) 126(4):593-601.
  • MU DQ, GAO LJ, PENG SY, LI JT: Significance of the mitochondrial D-loop alterations in hyperplastic pancreatic ductal cells in the vicinity of pancreatic cancer coexisting with chronic pancreatitis. Zhonghua Zhong Liu Za Zhi (2006) 28(6):433-437.
  • CHEN JZ, GOKDEN N, GREENE GF, GREEN B, KADLUBAR FF: Simultaneous generation of multiple mitochondrial DNA mutations in human prostate tumors suggests mitochondrial hyper-mutagenesis. Carcinogenesis (2003) 24(9):1481-1487.
  • COSTELLO LC, FRANKLIN RB: The clinical relevance of the metabolism of prostate cancer; zinc and tumor suppression: connecting the dots. Mol. Cancer (2006) 5:17.
  • DAKUBO GD, PARR RL, COSTELLO LC, FRANKLIN RB, THAYER RE: Altered metabolism and mitochondrial genome in prostate cancer. J. Clin. Pathol. (2006) 59(1):10-16.
  • JERONIMO C, NOMOTO S, CABALLERO OL et al.: Mitochondrial mutations in early stage prostate cancer and bodily fluids. Oncogene (2001) 20(37):5195-5198.
  • CHEN JZ, GOKDEN N, GREENE GF, MUKUNYADZI P, KADLUBAR FF: Extensive somatic mitochondrial mutations in primary prostate cancer using laser capture microdissection. Cancer Res. (2002) 62(22):6470-6474.
  • GOMEZ-ZAERA M, ABRIL J, GONZALEZ L et al.: Identification of somatic and germline mitochondrial DNA sequence variants in prostate cancer patients. Mutat. Res. (2006) 595(1-2):42-51.
  • JESSIE BC, SUN CQ, IRONS HR, MARSHALL FF, WALLACE DC, PETROS JA: Accumulation of mitochondrial DNA deletions in the malignant prostate of patients of different ages. Exp. Gerontol. (2001) 37(1):169-174.
  • HIGUCHI M, KUDO T, SUZUKI S et al.: Mitochondrial DNA determines androgen dependence in prostate cancer cell lines. Oncogene (2006) 25(10):1437-1445.
  • MAKI JKR, REGULY B, ALEXANDER J et al.: Mitochondrial genome deletion aids in the identification of both false and true negative prostate needle core biopsies. Am. J. Clin. Pathol. (2007) (In Press).
  • MEIERHOFER D, MAYR JA, FINK K, SCHMELLER N, KOFLER B, SPERL W: Mitochondrial DNA mutations in renal cell carcinomas revealed no general impact on energy metabolism. Br. J. Cancer (2006) 94(2):268-274.
  • WADA T, TANJI N, OZAWA A et al.: Mitochondrial DNA mutations and 8-hydroxy-2′-deoxyguanosine content in Japanese patients with urinary bladder and renal cancers. Anticancer Res. (2006) 26(5A):3403-3408.
  • NAGY A, WILHELM M, SUKOSD F, LJUNGBERG B, KOVACS G: Somatic mitochondrial DNA mutations in human chromophobe renal cell carcinomas. Genes Chromosomes Cancer (2002) 35(3):256-260.
  • NAGY A, WILHELM M, KOVACS G: Mutations of mtDNA in renal cell tumours arising in end-stage renal disease. J. Pathol. (2003) 199(2):237-242.
  • BIRCH-MACHIN MA: The role of mitochondria in ageing and carcinogenesis. Clin. Exp. Dermatol. (2006) 31(4):548-552.
  • PASSOS JF, SARETZKI G, AHMED S et al.: Mitochondrial dysfunction accounts for the stochastic heterogeneity in telomere-dependent senescence. PLoS Biol. (2007) 5(5):E110.
  • BIRKET M B-MM: The T414G mitochondrial DNA point mutation accumulates in a photoaging-dependent manner in human skin. Ageing Cell (2007) 6(5):557-564.
  • DURHAM SE, KRISHNAN KJ, BETTS J, BIRCH-MACHIN MA: Mitochondrial DNA damage in non-melanoma skin cancer. Br. J. Cancer (2003) 88(1):90-95.
  • HARBOTTLE A, KRISHNAN KJ, BIRCH-MACHIN MA: Implications of using the ND1 gene as a control region for real-time PCR analysis of mitochondrial DNA deletions in human skin. J. Invest. Dermatol. (2004) 122(6):1518-1521.
  • HARBOTTLE A, BIRCH-MACHIN MA: Real-time PCR analysis of a 3895 bp mitochondrial DNA deletion in nonmelanoma skin cancer and its use as a quantitative marker for sunlight exposure in human skin. Br. J. Cancer (2006) 94(12):1887-1893.
  • KRISHNAN KJ, HARBOTTLE A, BIRCH-MACHIN MA: The use of a 3895 bp mitochondrial DNA deletion as a marker for sunlight exposure in human skin. J. Invest. Dermatol. (2004) 123(6):1020-1024.
  • DEICHMANN M, KAHLE B, BENNER A, THOME M, HELMKE B, NAHER H: Somatic mitochondrial mutations in melanoma resection specimens. Int. J. Oncol. (2004) 24(1):137-141.
  • POETSCH M, DITTBERNER T, PETERSMANN A, WOENCKHAUS C: Mitochondrial DNA instability in malignant melanoma of the skin is mostly restricted to nodular and metastatic stages. Melanoma Res. (2004) 14(6):501-508.
  • TAKEUCHI H, FUJIMOTO A, HOON DS: Detection of mitochondrial DNA alterations in plasma of malignant melanoma patients. Ann. NY Acad. Sci. (2004) 1022:50-54.
  • ESHAGHIAN A, VLEUGELS RA, CANTER JA, MCDONALD MA, STASKO T, SLIGH JE: Mitochondrial DNA deletions serve as biomarkers of aging in the skin, but are typically absent in nonmelanoma skin cancers. J. Invest. Dermatol. (2006) 126(2):336-344.
  • KAMENISCH Y, WENZ J, METZLER G et al.: The mitochondrial DNA common deletion is present in most basal and squamous cell carcinoma samples isolated by laser capture microdissection but generally at reduced rather than increased levels. J. Invest. Dermatol. (2007) 127(2):486-490.
  • YEH JJ, LUNETTA KL, VAN ORSOUW NJ et al.: Somatic mitochondrial DNA (mtDNA) mutations in papillary thyroid carcinomas and differential mtDNA sequence variants in cases with thyroid tumours. Oncogene (2000) 19(16):2060-2066.
  • TONG BC, HA PK, DHIR K et al.: Mitochondrial DNA alterations in thyroid cancer. J. Surg. Oncol.(2003) 82(3):170-173.
  • MAXIMO V, SOARES P, LIMA J, CAMESELLE-TEIJEIRO J, SOBRINHO-SIMOES M: Mitochondrial DNA somatic mutations (point mutations and large deletions) and mitochondrial DNA variants in human thyroid pathology: a study with emphasis on Hurthle cell tumors. Am. J. Pathol. (2002) 160(5):1857-1865.
  • MAXIMO V, LIMA J, SOARES P, BOTELHO T, GOMES L, SOBRINHO-SIMOES M: Mitochondrial D-Loop instability in thyroid tumours is not a marker of malignancy. Mitochondrion (2005) 5(5):333-340.
  • WITTE J, LEHMANN S, WULFERT M, YANG Q, ROHER HD: Mitochondrial DNA mutations in differentiated thyroid cancer with respect to the age factor. World J. Surg. (2007) 31(1):51-59.
  • O'SHAUGHNESSY JA, KELLOFF GJ, GORDON GB et al.: Treatment and prevention of intraepithelial neoplasia: an important target for accelerated new agent development. Clin. Cancer Res. (2002) 8(2):314-346.
  • BANDELT HJ, LAHERMO P, RICHARDS M, MACAULAY V: Detecting errors in mtDNA data by phylogenetic analysis. Int. J. Legal Med. (2001) 115(2):64-69.
  • BRANDON M, BALDI P, WALLACE DC: Mitochondrial mutations in cancer. Oncogene (2006) 25(34):4647-4662.
  • BENZER S: On the topography of the genetic fine structure. Proc. Natl. Acad. Sci. USA (1961) 47(3):403-415.
  • MAITRA A, COHEN Y, GILLESPIE SE et al.: The human MitoChip: a high-throughput sequencing microarray for mitochondrial mutation detection. Genome Res. (2004) 14(5):812-819.
  • MEIERHOFER D, MAYR JA, EBNER S, SPERL W, KOFLER B: Rapid screening of the entire mitochondrial DNA for low-level heteroplasmic mutations. Mitochondrion (2005) 5(4):282-296.

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Order Reprints Request Corporate Permissions

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

Request Academic Permissions

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.

Related research

People also read lists articles that other readers of this article have read.

Recommended articles lists articles that we recommend and is powered by our AI driven recommendation engine.

Cited by lists all citing articles based on Crossref citations.
Articles with the Crossref icon will open in a new tab.